Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,542 | 58,247 | 210,484 | 43,167 | 34,236 |
| Marketable Securities | 202,519 | 214,139 | 77,070 | 93,286 | 113,846 |
| TOTAL | $258,689 | $276,538 | $290,771 | $138,414 | $150,671 |
| Non-Current Assets | |||||
| PPE Net | 1,120 | 939 | 728 | 779 | 840 |
| Other Non-Current Assets | 401 | 251 | 250 | 250 | 225 |
| TOTAL | $1,521 | $1,190 | $978 | $1,029 | $1,065 |
| Total Assets | $260,210 | $277,728 | $291,749 | $139,443 | $151,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,640 | 208 | 3,312 | 2,456 | 2,427 |
| Accrued Expenses | 5,942 | 7,595 | 3,849 | 3,038 | 4,210 |
| TOTAL | $13,582 | $7,803 | $7,247 | $5,579 | $6,720 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 86 | 85 | 83 |
| TOTAL | $372 | $288 | $185 | $206 | $228 |
| Total Liabilities | $13,954 | $8,091 | $7,432 | $5,785 | $6,948 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,426 | 34,411 | 34,175 | 27,530 | 27,284 |
| Common Shares | 34 | 34 | 34 | 27 | 27 |
| Retained earnings | -184,602 | -159,095 | -141,123 | -126,711 | -110,252 |
| TOTAL | $246,256 | $269,637 | $284,317 | $133,658 | $144,788 |
| Total Liabilities And Equity | $260,210 | $277,728 | $291,749 | $139,443 | $151,736 |